Apresentação oral: Tireoidite subaguda no contexto da COVID-19: Uma revisão integrativa

Notas do episódio

Camila Lopes de Araújo [1], Mateus Augusto dos Reis [2]. [1] Centro Universitário Unifacisa, Campina Grande - PB, [2] Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre - RS. Publicado no Caderno de Anais de Evento | DOI: https://doi.org/10.25248/anais.e6674.2021. Referências: BARRERA EC, et al. Subacute Thyroiditis Associated with COVID-19. Case reports in endocrinology, 2020; 2020: e8891539 BRANCATELLA A, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. The Journal of Clinical Endocrinology & Metabolism, 2020; 105(10): edgaa537. BRANCATELLA A, et al. Subacute thyroiditis after SARS-CoV-2 infection. The Journal of Clinical Endocrinology & Metabolism, 2020; 105(7): edgaa276. ROTONDI M, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. Journal of Endocrinological Investigation, 2020; 1: 1-6. TABASSOM A, EDDENS MA. De Quervain Thyroiditis. StatPearls Publishing, 2020; 1: eNBK526066.